- Will ProText Mobility, Inc. (OTCQB: TXTM) Find a Way to Monetize Applications for Mobile Communications Market?
- Can Tranzbyte Corporation (PINKSHEETS: ERBB) Overcome Concerns Surrounding Marijuana Business?
- SoundBite Communications (NASDAQ: SDBT) Surges Following Acquisition Agreement
- Is Regenerative Medicine Realistic for YaFarm Technologies (PINKSHEETS: YFRM)?
- Can Raptor Pharmaceutical Corp. (NASDAQ: RPTP) Turn FDA Approval into Big Payday Down the Road?
OTC Equity Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
Tagsaapl advertising alternative energy amex apple basic materials biopharmaceutical biotechnology cancer capital goods cloud computing copper drilling energy energy stocks exploration facebook fda fda approval gas gold gold mining google healthcare stocks investors ipad iphone mining NASDAQ natural gas nyse oil oil and gas otcbb penny stock penny stocks petroleum pharmaceutical pinksheets Pink Sheets s silver sprint stocks trading
OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.
Registration to our newsletter is FREE, Join today by entering your email below!
Category Archives: Penny Stocks
Now that GlobalWise Investments, Inc. (OTCBB: GWIV) has an Operating Company can they Generate Meaningful Revenue?
Last week GlobalWise Investments, Inc. (OTCBB: GWIV) announced that its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management systems in both the public and private sectors, had … Continue reading
Can Cardium Therapeutics (AMEX: CXM) Capitalize on FDA Approval and Commercialization Deal During First Quarter 2012?
Shareholders of Cardium Therapeutics (AMEX: CXM) have endured a lot over the years, waiting patiently for the day when the biotechnology company would gain FDA approval for a product and begin generating meaningful revenue. In October 2011 CXM received that … Continue reading
Adeona Pharmaceuticals (AMEX: AEN) Advancing Impressive Pipeline of Drug Product Candidates for the Treatment of Progressive Illnesses
Shares of Adeona Pharmaceuticals (AMEX: AEN) continue to climb, hitting a six-month high of 1.47 on Monday with trading volume remaining strong as the biotechnology company advances their impressive pipeline of various treatments for serious illnesses. Less than a month … Continue reading
Can Lee Enterprises (NYSE: LEE) Strengthen Digital Ventures to Attract More Advertising Revenue or is Pre-Packaged Chapter 11 Bankruptcy Plan All She Wrote for Publisher?
Lee Enterprises (NYSE: LEE) is hoping that bankruptcy proceeding to restructure part of their nearly $1 billion in debt will buy them enough time to monetize their digital ventures and stop the bleeding from their daily newspapers. The Iowa-based publisher … Continue reading
Can FiberTower Corporation (NASDAQ: FTWR) Put Miserable November Behind Them or Will Tough Times Carry Into 2012?
To say that FiberTower Corporation (NASDAQ: FTWR) experienced a disastrous November 2011 would be an understatement of epic proportions as the wireless backhaul services provider was forced to reduce their workforce by approximately 40%, failed to file their quarterly report … Continue reading
Is Cell Therapeutics, Inc. (NASDAQ: CTIC) Any Closer to FDA Approval for non-Hodgkin’s Lymphoma Drug Pixantrone?
The road to FDA approval for Cell Therapeutics, Inc. (NASDAQ: CTIC) has been one littered with speed bumps and potholes yet the biotechnology company now sits just a few months away from potentially clearing the final hurdle and advancing their … Continue reading
Can Capstone Turbine Corporation (NASDAQ: CPST) Restore Shareholder Faith and Attract Long-Term Investors?
Despite enormous potential and continued revenue growth it looks as if investors have had enough of Capstone Turbine Corporation (NASDAQ: CPST) as the clean energy technology company that produces low-emission microturbine systems continues to see their share price struggle. With … Continue reading
Unbelievable Opportunities for InVivo Therapeutics (OTCBB: NVIV) as Geron Corporation (NASDAQ: GERN) Discontinues Development of Research for Treatments of Spinal Cord Injuries
There are few things more attractive to an investor than a company that has no direct competition and on Monday InVivo Therapeutics (OTCBB: NVIV) all but earned that title after a stunning decision by Geron Corporation (NASDAQ: GERN) to immediately … Continue reading
Opexa Therapeutics, Inc. (NASDAQ: OPXA) Takes Big Step Forward with FDA as MS Drug Tovaxin Receives Fast-Track Designation but Investors Remain Cautious
More so than companies in any other industry biopharmaceutical companies know that it can take several years before their moment of opportunity ever arrives and the window to capitalize on that opportunity can close quick and once shut it may … Continue reading
Advanced Cell Technology, Inc. (OTCBB: ACTC) Presents Investors with the Ultimate High Risk High Reward Gamble
With high risk comes high reward and for those investors who believe in Advanced Cell Technology, Inc. (OTCBB: ACTC) the very chance that the biotechnology company will navigate their way through financial uncertainty and legal hurdles is worth a shot, … Continue reading